該雜志國際簡稱:J BREAST CANCER,是由出版商Korean Breast Cancer Society出版的一本致力于發(fā)布醫(yī)學(xué)研究新成果的的專業(yè)學(xué)術(shù)期刊。該雜志以O(shè)NCOLOGY研究為重點(diǎn),主要發(fā)表刊登有創(chuàng)見的學(xué)術(shù)論文文章、行業(yè)最新科研成果,扼要報(bào)道階段性研究成果和重要研究工作的最新進(jìn)展,選載對(duì)學(xué)科發(fā)展起指導(dǎo)作用的綜述與專論,促進(jìn)學(xué)術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學(xué)術(shù)影響力。
《Journal Of Breast Cancer》是一本以English/Korean為主的未開放獲取國際優(yōu)秀期刊,中文名稱乳腺癌雜志,本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展,探討行業(yè)發(fā)展的思路和方法,以促進(jìn)學(xué)術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用,也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.2,最新CiteScore 指數(shù)為3.8。
本刊近期中國學(xué)者發(fā)表的論文主要有:
Pokemon Inhibits Transforming Growth Factor β-Smad4-Related Cell Proliferation Arrest in Breast Cancer through Specificity Protein 1.
Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death.
Author: Fu J1, Zhong C2,3, Wu L4,5, Li D2,3, Xu T6, Jiang T7, Yang J8, Du J9.
Whole Exome Sequencing in the Accurate Diagnosis of Bilateral Breast Cancer: a Case Study.
Author: Li X1,2, Yang M2, Zhang Q3, Fan Y3, Zhu T2, Chen F2, Wang K1,2.
Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide.
Author: Ro J, Cheng FT, Sriuranpong V, Villalon A, Smruti BK, Tsang J, Yap YS; Asian Working Group for Eribulin Clinical Guide.
英文介紹
Journal Of Breast Cancer雜志英文介紹
The Journal of Breast Cancer (abbreviated as 'J Breast Cancer') is the official journal of the Korean Breast Cancer Society, which is issued quarterly in the last day of March, June, September, and December each year since 1998. All the contents of the Journal is available online at the official journal website (http://ejbc.kr) under open access policy. The journal aims to provide a forum for the academic communication between medical doctors, basic science researchers, and health care professionals to be interested in breast cancer. To get this aim, we publish original investigations, review articles, brief communications including case reports, editorial opinions on the topics of importance to breast cancer, and welcome new research findings and epidemiological studies, especially when they contain a regional data to grab the international reader's interest. Although the journal is mainly dealing with the issues of breast cancer, rare cases among benign breast diseases or evidence-based scientifically written articles providing useful information for clinical practice can be published as well.